Central ischemia, or cerebral stroke, is a condition that causes damage to the brain tissue when the blood flow to the brain is poor, or blocked. Rehabilitation therapies and integration with O2-therapies, has been shown to be useful, but limited, due to the inability to slow down neurodegeneration, or to recover the function of the nerve. Stem cell therapy constitutes, in the field of neurology and stroke therapy, the most effective treatment to catalyze muscle recovery, bladder function and greater range of movement. We have noticed a remarkable improvement in all degenerative conditions secondary to stroke, through the treatments with cells derived from the autologous adipose tissue, i.e. taken from the subject itself.
The new stimulating stem cell treatment has started to give significant results. This method allows you to collect cells and stem factors and return them back to the patient, in an activated form, often with a single procedure. Our studies and several other internationals show that autistic patients respond more significantly if treated at a younger age.
To patients of this age, it will be easier to respond to this treatment. The family members of our patients immediately noticed the benefits after a few days of treatment, but our scientific contacts will illustrate the current realistic experiences and expectations and the appropriate clinical research centres.